David A. Liebner
The Ohio State University(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, CAR-T cell therapy research, Vascular Tumors and Angiosarcomas, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,120 cited
- → NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021(2020)297 cited
- → Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial(2024)227 cited
- → Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial(2023)175 cited
- → Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases(2017)116 cited
- → NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022(2022)114 cited
- → MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples(2013)87 cited
- → TP53 mutational status is predictive of pazopanib response in advanced sarcomas(2015)67 cited
- → Treatment of Ipilimumab Induced Graves’ Disease in a Patient with Metastatic Melanoma(2016)59 cited
- → Thyroid cancer: pathogenesis and targeted therapy(2011)57 cited